integument
• when treated with doxycycline at P25
|
• fail to extend when treated with doxycycline in early postnatal life
• regression of sweat glands when treated with doxycycline at P20
|
• elevated lipid production when treated with doxycycline at P25
|
hypohidrosis
(
J:242196
)
• when treated with doxycycline at P20
|
• minitaturized when treated with doxycycline at P25
|
• delayed initiation of anagen until P29, when treated with doxycycline at P18
|
• premature when treated with doxycycline at P9
• however, hair follicle regression isnt observed when treated with doxycycline at P25
|
• slightly reduced proliferation when treated with doxycycline at P25
|
craniofacial
• flattened surface when treated with doxycycline in early postnatal life
|
• progressive from P7 when treated with doxycycline in early postnatal life
|
• progressive from P7 when treated with doxycycline in early postnatal life
|
• miniaturized when treated with doxycycline in early postnatal life
• decreased taste bud in fungiform and circumvallate papillae when treated with doxycycline in early postnatal life
|
cellular
• decreased basal cell proliferation in the filiform papillae and plantar epithelium, fungiform and circumvallate taste buds and sweat buds when treated with doxycycline at in either the early postnatal period, or in adult life
|
taste/olfaction
• miniaturized when treated with doxycycline in early postnatal life
• decreased taste bud in fungiform and circumvallate papillae when treated with doxycycline in early postnatal life
|
digestive/alimentary system
• flattened surface when treated with doxycycline in early postnatal life
|
• progressive from P7 when treated with doxycycline in early postnatal life
|
• progressive from P7 when treated with doxycycline in early postnatal life
|
• miniaturized when treated with doxycycline in early postnatal life
• decreased taste bud in fungiform and circumvallate papillae when treated with doxycycline in early postnatal life
|
endocrine/exocrine glands
• when treated with doxycycline at P25
|
• fail to extend when treated with doxycycline in early postnatal life
• regression of sweat glands when treated with doxycycline at P20
|
• elevated lipid production when treated with doxycycline at P25
|
hypohidrosis
(
J:242196
)
• when treated with doxycycline at P20
|
growth/size/body
• flattened surface when treated with doxycycline in early postnatal life
|
• progressive from P7 when treated with doxycycline in early postnatal life
|
• progressive from P7 when treated with doxycycline in early postnatal life
|
• miniaturized when treated with doxycycline in early postnatal life
• decreased taste bud in fungiform and circumvallate papillae when treated with doxycycline in early postnatal life
|